Usana Health Sciences Inc (USNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 9,290 | 42,060 | 37,576 | 26,969 | 16,537 |
| Depreciation Amortization | 10,245 | 22,229 | 16,345 | 10,786 | 5,084 |
| Income taxes - deferred | 1,355 | -6,744 | -4,047 | -4,918 | 2,547 |
| Accounts receivable | 1,004 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 1,975 | -1,269 | -3,044 | -3,310 | -1,718 |
| Other Working Capital | -9,499 | -13,003 | -7,502 | -16,096 | -11,493 |
| Other Operating Activity | 1,112 | 17,719 | 15,879 | 12,242 | 6,726 |
| Operating Cash Flow | $15,482 | $60,992 | $55,207 | $25,673 | $17,683 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,803 | -10,009 | -8,207 | -5,869 | -3,198 |
| Net Acquisitions | N/A | -203,336 | N/A | N/A | N/A |
| Other Investing Activity | -1,072 | 255 | 255 | 255 | -870 |
| Investing Cash Flow | $-3,875 | $-213,090 | $-7,952 | $-5,614 | $-4,068 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 23,687 | 689 | 691 | 537 |
| Common Stock Repurchased | -12,300 | -9,444 | -9,444 | -9,444 | -9,444 |
| Other Financing Activity | -2,167 | -4,690 | -4,622 | -4,546 | -3,039 |
| Financing Cash Flow | $-14,467 | $9,553 | $-13,377 | $-13,299 | $-11,946 |
| Exchange Rate Effect | 719 | -6,193 | 617 | -4,831 | -3,809 |
| Beginning Cash Position | 184,508 | 333,246 | 333,246 | 333,246 | 333,246 |
| End Cash Position | 182,367 | 184,508 | 367,741 | 335,175 | 331,106 |
| Net Cash Flow | $-2,141 | $-148,738 | $34,495 | $1,929 | $-2,140 |
| Free Cash Flow | |||||
| Operating Cash Flow | 15,482 | 60,992 | 55,207 | 25,673 | 17,683 |
| Capital Expenditure | -2,803 | -10,073 | -8,271 | -5,872 | -3,201 |
| Free Cash Flow | 12,679 | 50,919 | 46,936 | 19,801 | 14,482 |